Who has invested in Biolinq?

Mark Cuban are named among the investors backing Biolinq.

Biolinq Funding: $300M Raised, Series A (2017)

Biolinq funding overview

Biolinq is a Healthtech company based in San Diego. Biolinq has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in January 2017. The round record for Biolinq runs through 2017; nothing later has been disclosed. Investors on record include Mark Cuban.

Biolinq at a glance

Total raised: $300M
Latest round: Series A
Latest round date: January 2017
Industry: Healthtech
Headquarters: San Diego
Notable investors: Mark Cuban

Frequently asked about Biolinq funding

How much has Biolinq raised?: Biolinq has raised $300M in total disclosed funding across the rounds on record.
Who has invested in Biolinq?: Mark Cuban are named among the investors backing Biolinq.
What was the latest Biolinq funding round?: The most recent disclosed round is a Series A, announced in January 2017.
Where is Biolinq based?: Biolinq is based in San Diego.
What sector does Biolinq operate in?: Biolinq is tracked under Healthtech from San Diego, with $300M in disclosed funding.
When did Biolinq last raise?: The last disclosed Biolinq round closed in January 2017 at Series A.

Every Biolinq figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Healthtech companies in San Diego at a similar stage.

Biolinq Funding: $300M Raised, Series A (2017)

Biolinq funding overview

Biolinq at a glance

Frequently asked about Biolinq funding

Companies related to Biolinq (40)

Browse related funding lists (6)